HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 101/2/375    most recent 01515.2005v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Lu, Q. Articles by Rounds, S. Search for Related Content PubMed PubMed Citation Articles by Lu, Q. Articles by Rounds, S.

Transforming growth factor-₁-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation

Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Department of Medicine, Brown Medical School, Providence, Rhode Island

Submitted 1 December 2005 ; accepted in final form 24 April 2006

Lung edema due to increased vascular permeability is a hallmark of acute lung injury and acute respiratory distress syndrome. Both p38 and RhoA signaling events are involved in transforming growth factor (TGF)-₁-increased endothelial permeability; however, the mechanism by which these pathways cooperate is not clear. In this study, we hypothesized that TGF-₁-induced changes in endothelial monolayer permeability and in p38 and RhoA activation are dependent on Smad2 signaling. We assessed the role of Smad2 in p38 activation and the role of p38 in RhoA activation by TGF-₁. We found that TGF-₁ caused Smad2 phosphorylation between 0.5 and 1 h of exposure in endothelial cells. Knockdown of Smad2 protein prevented TGF-₁-induced p38 activation and endothelial barrier dysfunction. Furthermore, TGF-₁-enhanced RhoA activation was dependent on p38 activation. Inhibition of the RhoA-Rho kinase signaling pathway blunted TGF-₁-induced adherens junction disruption and focal adhesion complex formation. In addition, depletion of heat shock protein 27, a downstream signaling molecule of p38, did not prevent TGF-₁-induced endothelial barrier dysfunction. Finally, inhibition of de novo protein expression blunted TGF-₁-induced RhoA activation and endothelial barrier dysfunction. Our data indicate that TGF-₁ induces endothelial barrier dysfunction involving Smad2-dependent p38 activation, resulting in RhoA activation by possible transcriptional regulation.

heat shock protein 27; endothelium; cell signaling; endothelial monolayer permeability; small GTPases

This article has been cited by other articles:

				A. Antonov, C. Snead, B. Gorshkov, G. N. Antonova, A. D. Verin, and J. D. Catravas Heat Shock Protein 90 Inhibitors Protect and Restore Pulmonary Endothelial Barrier Function Am. J. Respir. Cell Mol. Biol., November 1, 2008; 39(5): 551 - 559. [Abstract] [Full Text] [PDF]

				Q. Lu Transforming growth factor-{beta}1 protects against pulmonary artery endothelial cell apoptosis via ALK5 Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L123 - L133. [Abstract] [Full Text] [PDF]

				F. Peng, B. Zhang, D. Wu, A. J. Ingram, B. Gao, and J. C. Krepinsky TGF{beta}-induced RhoA activation and fibronectin production in mesangial cells require caveolae Am J Physiol Renal Physiol, July 1, 2008; 295(1): F153 - F164. [Abstract] [Full Text] [PDF]

				Y. H. Lee, U. S. Kayyali, A. M. Sousa, T. Rajan, R. J. Lechleider, and R. M. Day Transforming Growth Factor-beta1 Effects on Endothelial Monolayer Permeability Involve Focal Adhesion Kinase/Src Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 485 - 493. [Abstract] [Full Text] [PDF]

				P. A. Singleton, L. Moreno-Vinasco, S. Sammani, S. L. Wanderling, J. Moss, and J. G. N. Garcia Attenuation of Vascular Permeability by Methylnaltrexone: Role of mOP-R and S1P3 Transactivation Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 222 - 231. [Abstract] [Full Text] [PDF]

				W.-L. Yeh, D.-Y. Lu, C.-J. Lin, H.-C. Liou, and W.-M. Fu Inhibition of Hypoxia-Induced Increase of Blood-Brain Barrier Permeability by YC-1 through the Antagonism of HIF-1{alpha} Accumulation and VEGF Expression Mol. Pharmacol., August 1, 2007; 72(2): 440 - 449. [Abstract] [Full Text] [PDF]

				Q. Lu, E. O. Harrington, J. Newton, M. Jankowich, and S. Rounds Inhibition of ICMT Induces Endothelial Cell Apoptosis through GRP94 Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 20 - 30. [Abstract] [Full Text] [PDF]

				O. L. Volger, J. O. Fledderus, N. Kisters, R. D. Fontijn, P. D. Moerland, J. Kuiper, T. J. van Berkel, A.-P. J.J. Bijnens, M. J.A.P. Daemen, H. Pannekoek, et al. Distinctive Expression of Chemokines and Transforming Growth Factor-{beta} Signaling in Human Arterial Endothelium during Atherosclerosis Am. J. Pathol., July 1, 2007; 171(1): 326 - 337. [Abstract] [Full Text] [PDF]

				G. Su, M. Hodnett, N. Wu, A. Atakilit, C. Kosinski, M. Godzich, X. Z. Huang, J. K. Kim, J. A. Frank, M. A. Matthay, et al. Integrin {alpha}vbeta5 Regulates Lung Vascular Permeability and Pulmonary Endothelial Barrier Function Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 377 - 386. [Abstract] [Full Text] [PDF]